Correction to: Scientific Reports https://doi.org/10.1038/s41598-020-64910-8, published online 15 May 2020


The original version of this Article contained errors.


In Figure 2, the data corresponding to the low-dose Desvenlafaxine (100 mg/day) and high-dose Desvenlafaxine (150 mg/day) treatment arms of Cheng, 2013 were not labelled. The original Figure 2 and accompanying legend appear below.

Figure 2
figure 2

Forest plot of changes in depressive symptoms in menopausal women with antidepressant treatments compared to those without. Note significantly better improvements in severity of depressive symptoms (k = 10, Hedges’ g = 0.44, 95% CI 0.32 to 0.57, p < 0.001) in subjects receiving antidepressants compared to that in controls.


Additionally, in the Methods section, under the sub-heading ‘Guidelines and protocol’,


“This systematic review and meta-analysis was conducted according to the guidelines presented in the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement18 (Supplementary Table S1). An a priori defined but unpublished protocol (available upon request to the authors) that was approved by the Institutional Review Board of Tri-Service General Hospital (TSGHIRB: B-105-12) was followed.”


now reads:


“This systematic review and meta-analysis was conducted according to the guidelines presented in the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement18 (Supplementary Table S1).”


The study protocol is reported in detail in the Methods section of the Article.


The original Article has been corrected.